Industry Report

Renewable Energy Q1 Highlights, and Companies to Watch in Q2 –Renewable Energy Market Continues Positive Trend in April, After a Strong First Quarter, outpacing the broader US Market. –March is the First Month of 2022 that Renewable Energy Funds See Positive Inflows. –Over the last 7 days, the Renewable Energy Industry has risen 4.6%, earnings… Continue reading Need-to-Know Renewable Energy Sector Microcaps in Q2 (AREC, ASTI, RNW, AMPS, VVPR)

Cybersecurity stocks are on the rise and investors should be watching closely. While it may be premature to call 2022 the Year of the Cybersecurity Penny Stock, it is worth mentioning that many of these smaller firms are having, what some would consider, their day in the sun. Global tensions are mounting around the threats… Continue reading 5 Cybersecurity Stocks That Rocked March

Cybersecurity stocks are topping the watchlist of investors. With President Biden’s recent warnings to firms about possible cyberattacks on US businesses and government office, western companies are beefing up their security. In an effort to protect their teams, operations, and assets, companies are looking for the best and brightest cybersecurity and IT providers. As a… Continue reading US Government Warns Businesses to Beef Up Cybersecurity, These Companies are Positioned to Help

Several factors are bringing the necessity of cybersecurity and information security back to the forefront of the minds of consumers and business leaders. Growing threats of cyberwarfare, the growing landscape of Web 3.0, and cyber terrorism all come to mind. Not to mention the Internet of Things (IoT) growing in our households and offices. We… Continue reading How Cybersecurity Penny Stocks Grow While Keeping Clients Safe

Biopharmaceutical stocks are targeting Crohn’s Disease in developing drugs in 2022. Research finds that this is a $13.7 billion market ripe for sector stock catalysts such as profit and dividends.  CATALYSTS BIOTECH INVESTORS SHOULD MONITOR Here are catalysts for buying into biopharmaceutical stocks targeting the development of Crohn’s Disease drugs in 2022: — The market… Continue reading Biopharma Stocks Targeting Crohn’s Disease In $13.7 Billion Market (STAB, ARNA, GILD and RDHL)

Biopharmaceutical stocks have profitable catalysts in 2022. As a sector, the biopharma industry dropped in 2021 as COVID-19 declined. Now new opportunities are here. Why It Matters To Investors Here are catalysts for buying into biopharmaceutical stocks in 2022: — The COVID-19 pandemic has settled into an endemic. Drug candidates remain profit makers but they… Continue reading Developing Biopharma Plays to Look at Now (STAB, MEIP, ABIO, AMPE, ZIVO, MREO)

Generation Hemp, Inc. (OTCMKTS: GENH) is one of the most diversified pure play hemp picks on the public markets.  Last week, Research and Markets released a report stating “the global industrial hemp market size is expected to reach USD $16.75 billion by 2030, registering a CAGR of 16.8%.”  GENH may be one of the largest… Continue reading GENH To Benefit From Fast-Growing Hemp Market Valuation

GENH, RKDA, SNES, EVGN, CLXT, AGFS, VEGI Geopolitical concerns over the Russian invasion of Ukraine are just the latest in a string of macroeconomic events pushing Agriculture stocks higher.  Supply chain problems, increasing energy costs, and rising global demand are creating higher commodity prices and thereby higher revenues for US agriculture.  The United States Department… Continue reading Alt. Agriculture Plays Set to Pop on Sanctions

Biotech Pharmaceutical stocks are building profits in 2022 while developing more effective COVID-19 vaccines and treatments for variants. Investors may buy these stocks now as new drugs reach the market.  Biotech Pharmaceutical analysts see the pandemic evolving into an endemic. Profits are ahead as global countries seek COVID-19 vaccines. Biotech R&D for COVID-19 specialty vaccines… Continue reading Biotech Pharmaceutical Sector Fights COVID-19